Pretty much bang on. This is as expected (well, for me, for the most part) and, if you're an interested holder, back to watching CC and medical devices divisions. Its clear that this has been a primary target for the past few months.
I would like for us to get some decisive action going forward on immunotherapies while concentrating on growing CC and medical devices. The HSV2 program has been a distraction for so long that it is time to pack it away.
Pretty much bang on. This is as expected (well, for me, for the...
-
- There are more pages in this discussion • 288 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.30 |
Change
-0.650(5.44%) |
Mkt cap ! $238.8M | |||
| Open | High | Low | Value | Volume |
| $11.71 | $11.83 | $11.24 | $346.8K | 29.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90 | $11.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.50 | 50 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |